These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15637173)

  • 1. How do central mineralocorticoid receptors modulate blood pressure?
    Funder JW
    Am J Physiol Regul Integr Comp Physiol; 2005 Feb; 288(2):R356-7. PubMed ID: 15637173
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the role of the central nervous system in mineralocorticoid hypertension?
    Gómez Sánchez EP
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of mineralocorticoid selectivity.
    Farman N
    Adv Nephrol Necker Hosp; 1999; 29():115-26. PubMed ID: 10561740
    [No Abstract]   [Full Text] [Related]  

  • 4. The nongenomic actions of aldosterone.
    Funder JW
    Endocr Rev; 2005 May; 26(3):313-21. PubMed ID: 15814845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney.
    DuPont JJ; Hill MA; Bender SB; Jaisser F; Jaffe IZ
    Hypertension; 2014 Apr; 63(4):632-7. PubMed ID: 24379184
    [No Abstract]   [Full Text] [Related]  

  • 6. Mineralocorticoid receptors: distribution and activation.
    Funder JW
    Heart Fail Rev; 2005 Jan; 10(1):15-22. PubMed ID: 15947887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptors in the metabolic syndrome.
    Zennaro MC; Caprio M; Fève B
    Trends Endocrinol Metab; 2009 Nov; 20(9):444-51. PubMed ID: 19800255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone and its mechanism of action: more questions than answers.
    Fuller PJ
    Aust N Z J Med; 1995 Dec; 25(6):800-7. PubMed ID: 8770356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptors and hypertension.
    Funder JW
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):53-5. PubMed ID: 7626506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple aspects of mineralocorticoid selectivity.
    Farman N; Rafestin-Oblin ME
    Am J Physiol Renal Physiol; 2001 Feb; 280(2):F181-92. PubMed ID: 11208593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone: good guy or bad guy in cerebrovascular disease?
    Rigsby CS; Cannady WE; Dorrance AM
    Trends Endocrinol Metab; 2005 Nov; 16(9):401-6. PubMed ID: 16213743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central regulation of blood pressure by the mineralocorticoid receptor.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Mol Cell Endocrinol; 2012 Mar; 350(2):289-98. PubMed ID: 21664417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of central mineralocorticoid receptors in cardiovascular disease.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Curr Hypertens Rep; 2001 Jun; 3(3):263-9. PubMed ID: 11353578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid modulation of central control of blood pressure.
    Gómez Sánchez EP
    Steroids; 1995 Jan; 60(1):69-72. PubMed ID: 7792819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in receptor-mediated mineralocorticoid hormone action.
    Agarwal MK
    Pharmacol Rev; 1994 Mar; 46(1):67-87. PubMed ID: 8190750
    [No Abstract]   [Full Text] [Related]  

  • 16. Reconsidering the roles of the mineralocorticoid receptor.
    Funder JW
    Hypertension; 2009 Feb; 53(2):286-90. PubMed ID: 19139379
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
    Bauersachs J; Jaisser F; Toto R
    Hypertension; 2015 Feb; 65(2):257-63. PubMed ID: 25368026
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone in vascular and metabolic dysfunction.
    Luther JM
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular determinants of mineralocorticoid selectivity.
    Farman N
    Curr Opin Nephrol Hypertens; 1999 Jan; 8(1):45-51. PubMed ID: 9914860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid-stimulating activity of adipose tissue.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.